Every three seconds, a bottle of Clarins' Double Serum sells globally, a testament to a product now in its ninth version, over 40 years after its initial creation, according to Groupeclarins.

Despite decades of market leadership and over 480 awards since 1985, Clarins continues to invest heavily in new scientific discoveries. The brand enhances its core offering to address emerging aging factors, a strategy that challenges conventional business logic.

Clarins appears poised to maintain its competitive edge by consistently integrating advanced botanical science into its hero products. Clarins' consistent integration of advanced botanical science into its hero products sets a high bar for the anti-aging skincare market, solidifying the brand's commitment to innovation in longevity research by 2026.

The Proven Power of Double Serum

  • After two weeks, users experienced a 21% increase in elasticity and a 14% increase in firmness, according to Groupeclarins.
  • Clinical results after four weeks showed a 25% increase in radiance, a 20% reduction in wrinkles, and a 12% reduction in pores.

The serum's 21% increase in elasticity, 14% increase in firmness, 25% increase in radiance, 20% reduction in wrinkles, and 12% reduction in pores confirm its long-standing efficacy. Consistent results validate its reputation for addressing key signs of skin aging.

Epi-Aging Defense: Clarins' Latest Breakthrough

Clarins' Double Serum now integrates breakthrough Epi-Aging Defense Technology, an exclusive discovery featuring NEW Organic Giant Provençal Reed extract, according to Clarinsusa. Clarins' laboratories proved this extract helps neutralize visible effects of epi-aging, which link to diet, exercise, UV rays, pollution, and other harsh environmental factors. The serum contains 22 cutting-edge botanicals and is protected by six patents.

Epi-Aging Defense Technology, an exclusive discovery featuring NEW Organic Giant Provençal Reed extract, combats contemporary environmental aging stressors. Clarins' continued investment underscores that market dominance demands relentless, science-backed evolution of a core offering.